Evidence map›Paper›PMID 29892027›Full record

ArticleNature chemistry2018

Controlling Pd(IV) reductive elimination pathways enables Pd(II)-catalysed enantioselective C(sp

Hojoon Park, Pritha Verma, Kai Hong, Jin-Quan Yu

Abstract read
In one paragraph

Article in Nature chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Article
  3. Enantioselective β-C(spJournal of the American Chemical Society · 2025
    Article
  4. Article
  5. Article
  6. Biocatalytic enantioselective C(spNature synthesis · 2024
    Article
  7. Article
  8. Review
  9. Benzylic C(spBeilstein journal of organic chemistry · 2024
    Review
  10. Article
  11. Article
  12. Pd(ii)-catalyzed β- and γ-C-(spChemical science · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. PdAngewandte Chemie (International ed. in English) · 2022
    Article
  17. Article
  18. PdJournal of the American Chemical Society · 2022
    Article
  19. OvercomingChemical science · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hojoon ParkDepartment of Chemistry, The Scripps Research Institute, La Jolla, California, USA.
Pritha VermaDepartment of Chemistry, The Scripps Research Institute, La Jolla, California, USA.
Kai HongDepartment of Chemistry, The Scripps Research Institute, La Jolla, California, USA.ORCID http://orcid.org/0000-0001-7341-4931
Jin-Quan YuDepartment of Chemistry, The Scripps Research Institute, La Jolla, California, USA. yu200@scripps.edu.ORCID http://orcid.org/0000-0003-3560-5774

Funding

Ligand-promoted Enantioselective C-H Activation ReactionsR01GM084019 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI YU, JIN-QUAN · 2008 to 2024
$9.5M
NIGMS NIH HHS R01 GM084019
6 · The paper itself

Abstract

The development of a Pd(II)-catalysed enantioselective fluorination of C(sp

Indexed as

HalogenationCarbonCatalysisHydrogenOxidation-ReductionPalladiumStereoisomerismSubstrate SpecificityCarbonHydrogenPalladium

Identifiers

PMID29892027
PMCPMC6289870

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.